1. Liu, Zihao, Shi, Yu, Lv, Li, Song, Erwei, Gong, Chang. 2022. Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 9, e2204649. doi:10.1002/advs.202204649. https://pubmed.ncbi.nlm.nih.gov/36285700/
2. Zeng, Wenfeng, Xiong, Lixiong, Wu, Wei, Chen, Jianing, Huang, Di. 2022. CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. In Oncogene, 42, 224-237. doi:10.1038/s41388-022-02540-2. https://pubmed.ncbi.nlm.nih.gov/36418470/
3. Lin, Zeyu, Li, Wenbin, Zhang, Heyun, Wang, Jie, Ouyang, Nengtai. 2015. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 3461-8. doi:10.1007/s13277-015-4172-x. https://pubmed.ncbi.nlm.nih.gov/26449829/
4. Korbecki, Jan, Olbromski, Mateusz, Dzięgiel, Piotr. 2020. CCL18 in the Progression of Cancer. In International journal of molecular sciences, 21, . doi:10.3390/ijms21217955. https://pubmed.ncbi.nlm.nih.gov/33114763/
5. Tang, Tao, Tao, Xuxiong, Bao, Xing, Ye, Jinjun, Yan, Yukuang. 2020. Mitofusin-2 (Mfn-2) Might Have Anti-Cancer Effect through Interaction with Transcriptional Factor SP1 and Consequent Regulation on Phosphatidylinositol Transfer Protein 3 (PITPNM3) Expression. In Medical science monitor : international medical journal of experimental and clinical research, 26, e918599. doi:10.12659/MSM.918599. https://pubmed.ncbi.nlm.nih.gov/31955176/
6. Köhn, Linda, Kohl, Susanne, Bowne, Sara J, Sandgren, Ola, Golovleva, Irina. . PITPNM3 is an uncommon cause of cone and cone-rod dystrophies. In Ophthalmic genetics, 31, 139-40. doi:10.3109/13816810.2010.486776. https://pubmed.ncbi.nlm.nih.gov/20590364/
7. Reinis, Ainars, Golovleva, Irina, Köhn, Linda, Sandgren, Ola. 2012. Ocular phenotype of CORD5, an autosomal dominant retinal dystrophy associated with PITPNM3 p.Q626H mutation. In Acta ophthalmologica, 91, 259-66. doi:10.1111/j.1755-3768.2011.02381.x. https://pubmed.ncbi.nlm.nih.gov/22405330/
8. Yang, Baoming, Jiao, Zhikai, Feng, Ningning, Zhang, Yueshan, Wang, Shunxiang. 2024. Long non-coding RNA MIR600HG as a ceRNA inhibits the pancreatic cancer progression through regulating the miR-1197/PITPNM3 axis. In Heliyon, 10, e24546. doi:10.1016/j.heliyon.2024.e24546. https://pubmed.ncbi.nlm.nih.gov/38312687/